Introduction {#s1}
============

During evolution, compartmentalization of the intracellular space has allowed to spatially restrict and optimize certain biochemical reactions and pathways. Therefore the lumens of different organelles have different properties in terms of ion concentrations, redox states and also pH. Organellar pH is tightly regulated ranging from neutral in the endoplasmic reticulum, to mildly acidic in early endosomes and highly acidic in late endosomes/lysosomes [@pone.0002758-Nishi1]. Acidic pH affects a number of biological events such as membrane trafficking, dissociation of ligand-receptor complexes after internalization and activation of lysosomal enzymes [@pone.0002758-Nishi1]. Although pH regulation can be modulated by a variety of factors such as proton leak, ClC chloride channels or Na,K-ATPases [@pone.0002758-Faundez1], [@pone.0002758-Grabe1], [@pone.0002758-Jentsch1], [@pone.0002758-Scheel1], it is primarily determined by the activity of the vacuolar ATPase (V-ATPase), which is expressed in all eukaryotes from yeast to mammals [@pone.0002758-Forgac1], [@pone.0002758-Kane1].

The V-ATPase is a multi-subunit complex composed of two domains, a peripheral V~1~ domain containing the ATPase activity and a membrane bound V~0~ domain responsible for translocation of protons across the membrane [@pone.0002758-Forgac1], [@pone.0002758-Marshansky1]. The central function of the V-ATPase is to pump protons from the cytoplasm to the lumen of organelles. In some specialized cells, the V-ATPase can also be found at the plasma membrane. Its role is then either to acidify the extracellular medium such as around osteoclasts and renal cells [@pone.0002758-Brown1], [@pone.0002758-Frattini1], [@pone.0002758-Li1], or to control the cytoplasmic pH as in neutrophiles and macrophages [@pone.0002758-Nanda1], [@pone.0002758-Hinton1]. The proton pump also appears to be involved in cancer through the promotion of metastasis and tumor progression and it is therefore considered as a potential drug target [@pone.0002758-Forgac1], [@pone.0002758-Hinton1].

Despite the importance of the V-ATPase in physiological and pathological processes, the exact mechanisms that control the activity of the V-ATPase remain to be fully elucidated. Four regulatory mechanisms have been described to date. The first is the reversible dissociation of the catalytic V~1~ domain from the membrane-associated V~0,~ which was observed in *S. cerevisiae* and *Manduca sexta* upon glucose deprivation and starvation respectively [@pone.0002758-Kane2], [@pone.0002758-Sumner1]. Change in V~1~/V~0~ association was also reported during maturation of murine dendritic cells [@pone.0002758-Trombetta1]. The second mechanism involves the abundance of the proton pump at a given site. In cells such as renal cells and osteoclasts, where the proton pump is at the cell surface, acid secretion was indeed found to be modulated by a differential surface expression of the V-ATPase through reversible exocytosis and endocytosis of the pump [@pone.0002758-Wagner1]. The third mechanism by which the activity of the V-ATPase could be modulated is by changing of the coupling efficiency between ATP hydrolysis and proton translocation, attributable to different isoforms of subunit V~0~a. This differential coupling efficiency was proposed to explain that lysosomes are more acidic than the Golgi [@pone.0002758-Nishi1], [@pone.0002758-Forgac1], [@pone.0002758-Nelson1] [@pone.0002758-KawasakiNishi1]. Finally, it has been proposed that specific lipids can affect the activity of the V-ATPase. More specifically it was shown in yeast that sphingolipids with a C26 acyl group are required for generating V1 domains with ATPase activity [@pone.0002758-Chen1]. Interestingly, several V-ATPase inhibitors where shown to incorporate into the lipid bilayer and affect the V-ATPase structural flexibility [@pone.0002758-Dixon1], [@pone.0002758-Dixon2].

In this study, our interest was to get a better understanding of how pH is controlled along the endocytic pathway in mammalian cells, since most studies on V-ATPase regulation where performed in yeast. We found that the increased acidity of late endosomes is not due to a higher density of proton pumps but rather to an increase in the V~1~/V~0~ ratio when compared to early endosomes. Thus regulation would occur via reversible association/dissociation, reminiscent of what occurs found in yeast. Additionally, we found that the lipid environment of the V-ATPase is of essential importance for its activity, suggesting a second mode of regulation and highlighting that the V-ATPase activity is modulated by multiple, simultaneously operating, mechanisms.

Results {#s2}
=======

DRM association of all the subunits of the V-ATPase {#s2a}
---------------------------------------------------

Endosomes, and in particular late endosomes, are well known to be composed of mosaics of domains [@pone.0002758-Gruenberg1], [@pone.0002758-Miaczynska1]. We have shown that late endosomes, in particular, contain raft-like domains that are rich in cholesterol and sphingomyelin and resistant to extraction in non-ionic detergents at 4°C [@pone.0002758-Fivaz1], [@pone.0002758-Sobo1]. To further characterize late endosomal DRMs, we have here performed a proteomic analysis. Proteomics analysis of DRM fractions have been reported in numerous studies [@pone.0002758-Blonder1], [@pone.0002758-Foster1], [@pone.0002758-MacLellan1], [@pone.0002758-Karsan1], [@pone.0002758-Adam1], but this is the first that proteomics was performed on DRMs of a purified endocytic organelle. As previously, late endosomes were obtained from Baby Hamster Kidney cells, since a well-established subcellular fractionation protocol to purify late endosomes is available for this cell line [@pone.0002758-Fivaz1], [@pone.0002758-Aniento1]. We have previously shown using surface biotinylation of proteins that this fraction does not contain detectable amounts of plasma membrane [@pone.0002758-vanderGoot1]. Moreover this late endosomal fraction is not contaminated by Golgi, endoplasmic reticulum, early endosomal or caveolar membranes, as shown by western blotting using marker proteins [@pone.0002758-Sobo2]. It is likely that the high purity of this fraction is due to the fact that the late endosomal fraction has a very low buoyancy and thus migrates through the entire gradient to the top of the tube, far away from all other cellular compartments. The llate endosomal fraction was subsequently submitted to solubilization in triton X-100 at 4°C and the Detergent-Resistant-Membranes (DRMs, fractions 1 and 2 from the top of the gradient) were separated from the Detergent-Soluble-Membranes (DSMs, fractions 5 and 6) using floatation gradients. The proteomes of both the DRMs and DSMs were determined by mass spectrometry after appropriate trypsinization and sample preparation.

Some 126 and 161 proteins were identified in the DRM and DSM fractions respectively, 44 of which were found in both fractions ([Table 1](#pone-0002758-t001){ref-type="table"} and [2](#pone-0002758-t002){ref-type="table"}), which jointly provide a global proteome of the organelle. Reassuringly, known late endosome specific proteins such as the small GTPase Rab7, the lysosomal glycoprotein LAMP2, or the NPC1 protein involved in Niemann Pick type C disease [@pone.0002758-Maxfield1] were found. Also the DRM fraction contained most of the well-documented rafts markers such as caveolin-1 and 2 --involved in the formation of caveolae, in signaling and in lipid regulation [@pone.0002758-Parton1]--, erlin 2, --a DRM associated ER protein [@pone.0002758-Browman1], flotillins 1 and 2 [@pone.0002758-Morrow1], which were also found in the DSM in agreement with detectable amounts by western blotting [@pone.0002758-Fivaz1], stomatin and the hyaluronic acid receptor CD44 [@pone.0002758-Oliferenko1].

10.1371/journal.pone.0002758.t001

###### Proteins identified in the late endosomal DRM fraction.

![](pone.0002758.t001){#pone-0002758-t001-1}

  Numb    Uniprot Numb                             Protein name                                     Protein family           Mascot score     Mw     Cov (%)   Nb pep
  ------ -------------- ------------------------------------------------------------------ -------------------------------- -------------- -------- --------- --------
  1          P56564                    Excitatory amino acid transporter 1                           AA transport               150.46      59584     7.21       2
  2        **Q3UFR4**                **Neutral amino acid transporter ASCT2**                        AA transport               186.95      58327     6.42       3
  3          Q9JKY1                              Peroxiredoxin-1                                Cell redox homeostasis          45.56       22248     5.45       1
  4        **Q71FK5**                 **Actin, cytoplasmic 1 (Beta-actin)**                          Cytoskeleton              1034.51      41710     54.35      15
  5          P63260                     Actin, cytoplasmic 2 (Gamma-actin)                           Cytoskeleton              1071.66      41766     54.35      15
  6          Q7TSH1                               Actr3b protein                                     Cytoskeleton                55.1       48539     2.49       1
  7          Q8BMK4                     Cytoskeleton-associated protein 4                            Cytoskeleton               74.92       60655      2.9       1
  8          P47757                    F-actin-capping protein subunit beta                          Cytoskeleton               44.23       31195     3.53       1
  9          Q5M810                               Myo1g protein                                      Cytoskeleton               114.37      58945      7.1       2
  10         Q3UFT0                           myosin heavy chain IX                                  Cytoskeleton               108.31      110908    4.27       2
  11         Q63355                            Myosin I heavy chain                                  Cytoskeleton              1530.65      118017    27.33      23
  12         P14869                     Myosin regulatory light chain 2-A                            Cytoskeleton               80.24       34195     3.87       1
  13         P46735                                 Myosin-Ib                                        Cytoskeleton               45.16       128447    0.77       1
  14         Q9ERB6                           Nuclear myosin I beta                                  Cytoskeleton              1508.15      119802    27.09      23
  15         P30427                                 Plectin-1                                        Cytoskeleton               42.29       533214    0.23       1
  16         Q9EPK2                                Protein XRP2                                      Cytoskeleton               39.92       39220     3.93       1
  17       **P54116**                              **Stomatin**                                      Cytoskeleton               192.32      31384     15.79      3
  18         P68372                           Tubulin beta-2C chain                                  Cytoskeleton               144.93      49799     6.42       3
  19         Q3TWV0                                  vimentin                                        Cytoskeleton               97.46       53633     4.72       2
  20       **Q8K3H8**                              **Calnexin**                                      ER chaperone               48.48       67422     2.61       1
  21         Q8BFZ9                             Erlin-2 precursor                                    ERAD pathway               129.07      37849     10.76      3
  22       **O08917**                            **Flotillin-1**                                  Flotillin complex             900.61      47484     42.92      14
  23       **Q9Z2S9**                            **Flotillin-2**                                  Flotillin complex             782.94      47009     34.43      12
  24       **P17809**                **Glucose transporter type 1 (GLUT-1)**                     Glucose transporter            105.89      53899     3.68       2
  25         Q3UAZ6           ATP-binding cassette, sub-family B (MDR/TAP), member 6               Heme homeostasis             41.06       84765     1.95       1
  26         O88783                            Coagulation factor V                                  Ion binding                43.16       247076    0.45       1
  27         Q6PFA8                               Moxd1 protein                                      Ion binding                89.33       69734     3.63       2
  28         Q3TVE3                similar to S100 calcium-binding protein A16                       Ion binding                49.01       14287     8.53       1
  29       **Q7TMC7**                          **Ab2-417 (Cc1-8)**                                  Ion transport               97.43       107343    3.08       2
  30         P51881                           ADP/ATP translocase 2                                 Ion transport               92.37       32779     7.74       2
  31       **Q8VDN2**                 **Na(+)/K(+) ATPase alpha-1 subunit**                         Ion transport               634.88      112910    14.91      10
  32       **Q3TX38**                 **voltage-dependent anion channel 3**                         Ion transport               143.97      30733     12.19      3
  33       **Q9Z2L0**    **Voltage-dependent anion-selective channel protein 1 (VDAC-1)**           Ion transport               107.19      30606     7.55       2
  34       **Q60930**    **Voltage-dependent anion-selective channel protein 2 (VDAC-2)**           Ion transport               49.07       31713     4.07       1
  35         O08532         Voltage-dependent calcium channel subunit alpha-2/delta-1               Ion transport               508.19      124551    12.37      9
  36       **P51909**                          **Apolipoprotein D**                                Lipid biogenesis             58.56       21596     6.12       1
  37         Q9JKU9                       Sigma 1 receptor beta variant                            Lipid biogenesis             42.74       21589     6.63       1
  38       **P00762**                    **Anionic trypsin-1 precursor**                              Peptidase                 81.74       25943     8.51       1
  39       **P07356**                             **Annexin A2**                            Phospholipid binding/modifying      339.59      38521      24        6
  40         Q8BG11                                cadherin 13                                     Protein binding              43.41       78137     2.39       1
  41         Q8BFU4                          GAIP/RGS19 short isoform                              Protein binding              48.57       22240     6.44       1
  42       **Q4FCR4**                 **Intercellular adhesion molecule 1**                        Protein binding              72.74       53809     2.86       1
  43         P70490                           Lactadherin precursor                                Protein binding              43.23       47382     2.56       1
  44         Q6DI58                               Rpl12 protein                                    Protein binding              53.03       22973     7.21       1
  45         Q6PDW1                         40S ribosomal protein S12                            Protein biosynthesis           108.17      14505     16.79      1
  46       **P62629**                    **Elongation factor 1-alpha 1**                         Protein biosynthesis           50.37       50082     5.27       1
  47         Q3U561                           ribosomal protein L10A                             Protein biosynthesis           70.68       24800     5.78       1
  48         Q3UBI6                            ribosomal protein L7                              Protein biosynthesis           53.16       31331     3.87       1
  49         Q9QWC2                            Ribosomal protein P2                              Protein biosynthesis           40.29        5063     23.08      1
  50         Q3UCL7                            ribosomal protein S3                              Protein biosynthesis           136.27      26658     16.12      3
  51       **Q62186**       **Translocon-associated protein subunit delta precursor**            Protein biosynthesis           61.03       18924      6.4       1
  52         Q3S4T7                 78 kDa glucose-regulated protein precursor                     Protein folding              268.69      72284     8.68       5
  53       **P24369**                           **Cyclophilin B**                                  Protein folding               38.8       22699     6.31       1
  54       **P30412**                           **Cyclophilin C**                                  Protein folding              253.35      22780     22.71      4
  55         Q3KQJ4                          Hspa8 protein (Fragment)                              Protein folding              252.63      62117     8.87       5
  56         Q6AYQ9                    Peptidyl-prolyl cis-trans isomerase                         Protein folding              211.16      22995     20.1       4
  57         P62858                         40S ribosomal protein S28                             Protein processing            60.75        7836     16.9       1
  58         Q9R0Y5                        Adenylate kinase isoenzyme 1                           Protein processing            51.75       21526     6.67       1
  59         Q9WU83                   Dolichol-phosphate mannosyltransferase                      Protein processing            42.88       29636     4.09       1
  60       **P57716**                        **Nicastrin precursor**                              Protein processing            43.83       78441     2.24       1
  61       **Q6AXQ3**                   **Viral oncogene yes-1 homolog 1**                        Protein processing            249.57      54236      14        5
  62         P25286                               V0 subunit a1                                    Proton transport             419.99      96265     9.03       7
  63         Q5XK06                                V0 subunit C                                    Proton transport             45.38       20434     9.73       1
  64         P51863                                V0 subunit d                                    Proton transport             210.04      40275     7.92       3
  65         Q3U5W3                          V1 subunit A, isoform 1                               Proton transport             790.08      68211     30.97      13
  66         P62814                       V1 subunit B2 (brain isoform)                            Proton transport             639.65      56515     29.82      12
  67         Q9Z1G3                                V1 subunit C                                    Proton transport             176.41      43702     10.08      3
  68         P57746                                V1 subunit D                                    Proton transport             47.54       28351     6.23       1
  69         Q3UK59                           V1 subunit E isoform 1                               Proton transport             357.23      26145      27        5
  70         Q9D1K2                                V1 subunit F                                    Proton transport             91.08       13362     17.36      2
  71         Q8R2H0                               V1 subunit G2                                    Proton transport             165.4       13659     12.9       2
  72         Q8BVE3                                V1 subunit H                                    Proton transport              38.7       55819     3.16       1
  73         P63001                 Ras-related C3 botulinum toxin substrate 1                   Ras-related protein            345.83      21436     32.47      6
  74         Q99JI6                    Ras-related protein Rap-1b precursor                      Ras-related protein            291.41      20812     32.28      5
  75       **P61226**                **Ras-related protein Rap-2b precursor**                    Ras-related protein            142.64      20491     20.43      2
  76       **P62071**                **Ras-related protein R-Ras2 precursor**                    Ras-related protein            125.1       23385     13.21      2
  77         Q60522                           CD44 antigen precursor                                   Receptor                 127.99      46778     5.41       2
  78       **P17852**                     **Integrin alpha-3 precursor**                               Receptor                 150.39      118475    2.79       2
  79         Q9ERD4               Ankyrin repeat-rich membrane-spanning protein                       Signalling                45.27       190414    1.21       1
  80         P32261                     Antithrombin-III precursor (ATIII)                            Signalling                68.51       51971     2.54       1
  81         Q7TMA5                            Apolipoprotein B-100                                   Signalling                276.81      535688    1.36       5
  82       **P61022**                    **Calcium-binding protein p22**                              Signalling                93.05       22287     13.86      2
  83       **P62204**                             **Calmodulin**                                      Signalling                331.96      16696     54.97      4
  84         Q9DAS9            G protein G(I)/G(S)/G(O) subunit gamma-12 precursor                    Signalling                40.48        7861     22.54      1
  85       **P62874**              **G protein G(I)/G(S)/G(T) subunit beta-1**                        Signalling                195.17      37222     10.06      2
  86       **P62880**              **G protein G(I)/G(S)/G(T) subunit beta-2**                        Signalling                171.96      37176     10.09      2
  87         P38403                G protein G(k) subunit alpha (G(i) alpha-3)                        Signalling                177.74      40447     11.44      3
  88         P08752                  Guanine nucleotide-binding protein G(i)                          Signalling                264.43      40314     14.21      4
  89         Q6R0H7       Guanine nucleotide-binding protein G(s) subunit alpha isoforms              Signalling                206.68      121429    3.26       4
  90         Q3U2W7                       Kirsten rat sarcoma oncogene 2                              Signalling                67.25       21400     6.19       1
  91       **P62977**                             **Ubiquitin**                                       Signalling                112.42       8560     32.47      2
  92         Q6IN24                                 Galectin 8                                      sugar binding               96.51       36050     5.81       2
  93       **Q9CQW2**              **ADP-ribosylation factor-like protein 8B**                       Trafficking                77.66       21525     19.49      2
  94         P17426                        AP-2 complex subunit alpha-1                              Trafficking                110.59      107596    2.45       2
  95         Q9DBG3                        AP-2 complex subunit beta-1                               Trafficking                 92.4       104516    4.95       2
  96         P62743                        AP-2 complex subunit sigma-1                              Trafficking                50.54       17007     9.74       1
  97         P49817                                 Caveolin-1                                       Trafficking                289.28      20525     40.32      6
  98         Q8VIK7                                 Caveolin-2                                       Trafficking                46.57       18163      9.7       1
  99         P08712                                Endoplasmin                                       Trafficking                41.48       46765     3.29       1
  100        Q6WRU0                         GPI-anchored protein GREG                                Trafficking                 49.7       22812     5.31       1
  101        Q5SW87                                    RAB1                                          Trafficking                144.33      15016     27.94      3
  102      **Q4FJL0**                               **RAB10**                                        Trafficking                129.62      22527     16.67      3
  103      **Q91V41**                               **RAB14**                                        Trafficking                51.95       23751     6.05       1
  104        P35293                                   RAB18                                          Trafficking                48.64       23021     5.26       1
  105      **P53994**                               **RAB2A**                                        Trafficking                177.51      23533     20.19      3
  106      **P61021**                               **RAB5B**                                        Trafficking                36.86       23692     6.51       1
  107      **Q3TCT9**                               **RAB5C**                                        Trafficking                132.96      23397     21.23      3
  108      **Q3U4W5**                                **RAB6**                                        Trafficking                41.42       23531     5.63       1
  109      **Q4AEF6**                                **RAB7**                                        Trafficking                163.59      23489     17.37      3
  110        P13596                                   RAB7a                                          Trafficking                140.11      94599     3.49       2
  111        P63321                              Ral-A precursor                                     Trafficking                121.59      23538     12.68      3
  112      **Q3UZ06**              **SEC22 vesicle trafficking protein-like 1**                      Trafficking                67.84       18935     6.98       1
  113        O70377                                  SNAP-23                                         Trafficking                84.91       23220     18.48      2
  114        Q5F234                                 Syntaxin 8                                       Trafficking                66.07       26908     7.38       1
  115      **O35587**               **Transmembrane protein Tmp21 precursor**                        Trafficking                90.42       24805     8.89       2
  116        Q9WV55                     VAMP-associated protein A (VAMP-A)                           Trafficking                93.96       27262     5.67       2
  117        O88384          Vesicle transport v-SNARE protein Vti1-like 1 (Vti1-rp1)                Trafficking                53.28       26697     4.96       1
  118      **Q791V5**                  **Mitochondrial carrier homolog 2**                            Tranporter                52.55       33477     7.89       1
  119        O54724                 Polymerase I and transcript release factor                      Transcription               138.19      43927     7.27       2
  120      **Q9Z239**                      **Phospholemman precursor**                         Unknown cellular process         52.05       10316     12.9       1
  121        Q3TH64                                   Q3TH64                                   Unknown cellular process         40.29       16236     23.13      1
  122        Q6UL10                                   Q6UL10                                   Unknown cellular process         45.96       223986    0.59       1
  123        Q9QUR8                          Semaphorin-7A precursor                           Unknown cellular process         60.59       74946     1.91       1
  124        Q3TJK3                 serine (or cysteine) proteinase inhibitor                  Unknown cellular process         119.34      46505       9        2
  125      **Q3TIP1**                      **solute carrier family 3**                         Unknown cellular process         40.75       10997     17.17      1
  126      **Q6P791**                  **UPF0404 protein C11orf59 homolog**                    Unknown cellular process         137.22      17710     16.25      2

Mw: theoretical molecular weight (kDa). Cov (%), protein sequence coverage; Nb pep, number of peptides assigned. In bold are the proteins found in both DRM and DSM fractions.

10.1371/journal.pone.0002758.t002

###### Proteins identified in the late endosomal DSM fraction.

![](pone.0002758.t002){#pone-0002758-t002-2}

  Numb    Uniprot Numb                                Protein name                                        Protein family            Mascot score     Mw     Cov (%)   Nb pep
  ------ -------------- ------------------------------------------------------------------------ --------------------------------- -------------- -------- --------- --------
  1          Q60458                        Cationic amino acid transporter-1                               AA transport                97.13       35185     11.6       2
  2          Q8VII6                        Choline transporter-like protein 1                              AA transport                47.02       73043     1.81       1
  3        **Q3UFR4**                   **Neutral amino acid transporter ASCT2**                           AA transport                174.62      58327     6.42       3
  4          P17897                           Lysozyme C type P precursor                                  Bacteriolytic               49.06       16783     7.89       1
  5          Q920L2           Succinate dehydrogenase \[ubiquinone\] flavoprotein subunit             Carbohydrate metabolism          55.31       71570     2.15       1
  6          Q9Z0G9                                    Claudin-3                                           Cell adhesion               85.27       23269     13.27      2
  7          Q3T1H3                                  Ncam1 protein                                         Cell adhesion               400.3       93515     11.65      6
  8          Q91Z81                                  ERP57 protein                                    Cell redox homeostasis           493.44      56761     20.93      9
  9          P20070                          NADH-cytochrome b5 reductase 3                           Cell redox homeostasis           243.98      34022     12.94      4
  10         Q60451                       NADPH-cytochrome P450 oxidoreductase                        Cell redox homeostasis           46.89       75803      1.6       1
  11         Q52KJ9                         Thioredoxin domain containing 1                           Cell redox homeostasis           120.38      31415     10.53      2
  12         Q3THH1                         thioredoxin domain containing 5                           Cell redox homeostasis           326.36      48627     11.54      4
  13       **Q71FK5**                    **Actin, cytoplasmic 1 (Beta-actin)**                             Cytoskeleton                583.76      41710     37.2       10
  14         P18760                                    Cofilin-1                                           Cytoskeleton                111.27      18417     13.77      2
  15         P47753                     F-actin-capping protein subunit alpha-1                            Cytoskeleton                54.64       32788     3.36       1
  16         P62962                                    Profilin-1                                          Cytoskeleton                50.02       14816     10.45      1
  17       **P54116**                                 **Stomatin**                                         Cytoskeleton                48.34       31384     4.21       1
  18         P68361                              Tubulin alpha-1B chain                                    Cytoskeleton                55.57       50120     1.98       1
  19         P69893                               Tubulin beta-5 chain                                     Cytoskeleton                115.73      49639     4.43       2
  20         P02544                                     Vimentin                                           Cytoskeleton                305.99      53566     11.93      5
  21       **Q8K3H8**                                 **Calnexin**                                         ER chaperone                119.25      67224     5.07       2
  22       **O08917**                               **Flotillin-1**                                      Flotillin complex             383.61      47484     20.19      6
  23       **Q9Z2S9**                               **Flotillin-2**                                      Flotillin complex             445.33      47009     20.84      7
  24         Q9Z1W7                                       GP50                                    Folding and Transport regulator      264.19      46569     14.89      4
  25         Q3TWF2                            heat shock 70kD protein 5                          Folding and Transport regulator      909.11      72419     27.66      15
  26         P19378                        Heat shock cognate 71 kDa protein                      Folding and Transport regulator      500.69      70761     16.49      9
  27         P35293                          Heat shock protein HSP 90-beta                       Folding and Transport regulator       44.7       23021     5.26       1
  28       **P17809**                   **Glucose transporter type 1 (GLUT-1)**                         Glucose transporter            51.34       53899     1.64       1
  29         P05064                         Fructose-bisphosphate aldolase A                                Glycolysis                 64.07       39200     5.62       1
  30         Q3THM2                     glyceraldehyde-3-phosphate dehydrogenase                            Glycolysis                 91.15       35789     8.11       2
  31         O70252                                 Heme oxygenase 2                                     Heme homeostasis              85.89       35716     12.35      2
  32         Q1MWP8                            EH-domain containing 4-KJR                                   Ion binding                38.62       61613     1.96       1
  33         Q3U7R1                        Extended-synaptotagmin-1 (E-Syt1)                                Ion binding                114.58      121478    2.63       2
  34         Q6PFA8                        N-acylsphingosine amidohydrolase 1                               Ion binding                45.67       69734     1.58       1
  35         Q05186                            Reticulocalbin-1 precursor                                   Ion binding                42.58       38090     4.34       1
  36       **Q7TMC7**                             **Ab2-417 (Cc1-8)**                                      Ion transport               110.61      107343    2.97       2
  37         Q3V132                              ADP/ATP translocase 4                                     Ion transport               47.67       35235     3.75       1
  38         P15999                            ATP synthase subunit alpha                                  Ion transport               58.99       59717     2.21       1
  39         P56480                            ATP synthase subunit beta                                   Ion transport               140.84      56265     5.09       2
  40         O55143                      endoplasmic reticulum calcium ATPase 2                            Ion transport               107.98      114784    3.45       2
  41         Q09143                 High affinity cationic amino acid transporter 1                        Ion transport               98.32       67048     3.94       2
  42         Q91VS7                      Microsomal glutathione S-transferase 1                            Ion transport               83.61       17409     7.59       1
  43       **Q8VDN2**                    **Na(+)/K(+) ATPase alpha-1 subunit**                             Ion transport               621.11      112910    16.37      10
  44         P11505                  Plasma membrane calcium-transporting ATPase 1                         Ion transport               522.49      138632    10.32      11
  45       **Q3TX38**                    **voltage-dependent anion channel 3**                             Ion transport               232.58      30733     19.35      4
  46       **Q9Z2L0**       **Voltage-dependent anion-selective channel protein 1 (VDAC-1)**               Ion transport               245.29      30606     23.38      5
  47       **Q60930**       **Voltage-dependent anion-selective channel protein 2 (VDAC-2)**               Ion transport               177.68      31713     14.93      3
  48       **P51909**                             **Apolipoprotein D**                                   Lipid biogenesis              62.59       21596     6.12       1
  49         Q8BLF1                         Arylacetamide deacetylase-like 1                             Lipid biogenesis              122.47      45711     5.06       2
  50         O88531                    Palmitoyl-protein thioesterase 1 precursor                        Lipid biogenesis              80.12       34467     4.79       1
  51         Q9JKU9                          Sigma 1 receptor beta variant                               Lipid biogenesis              52.54       21589     6.63       1
  52         Q9R1J0                    Sterol-4-alpha-carboxylate 3-dehydrogenase                        Lipid biogenesis              42.14       40660     3.52       1
  53         Q69ZN7                         Myoferlin (Fer-1-like protein 3)                              Membrane repair              152.49      236053    2.38       3
  54         Q99KV1                   DnaJ homolog subfamily B member 11 precursor                       mRNA modification             41.04       40530     2.99       1
  55       **P00762**                       **Anionic trypsin-1 precursor**                                  Peptidase                 81.51       25943     8.51       1
  56         P07150                                    Annexin A1                                 Phospholipid binding/modifying       223.58      38674     7.12       3
  57       **P07356**                                **Annexin A2**                               Phospholipid binding/modifying       934.99      38521     40.57      14
  58         Q3UCL0                                    annexin A4                                 Phospholipid binding/modifying       177.72      35893     9.51       3
  59         P48037                                    Annexin A6                                 Phospholipid binding/modifying       367.61      75575     14.26      8
  60         P14824                                    Annexin A6                                 Phospholipid binding/modifying       359.86      75707     13.66      8
  61         Q8VDP6                          Phosphatidylinositol synthase                        Phospholipid binding/modifying       37.88       23583     5.14       1
  62         Q8R366                  Immunoglobulin superfamily member 8 precursor                        Protein binding              115.51      64970     3.73       2
  63       **Q4FCR4**                    **Intercellular adhesion molecule 1**                            Protein binding              186.97      53809     8.38       3
  64         P21956                              Lactadherin precursor                                    Protein binding              47.39       51236     2.37       1
  65         P70117                       Pancreas cancer-associated protein 4                            Protein binding              166.84      64358     6.67       3
  66         P70206                               Plexin-A1 precursor                                     Protein binding              75.36       210965     1.3       2
  67         Q9WV91              Prostaglandin F2 receptor negative regulator precursor                   Protein binding              91.15       98646     3.46       2
  68         Q5SS40      Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein           Protein binding              50.26       29155     4.91       1
  69       **P62629**                       **Elongation factor 1-alpha 1**                            Protein biosynthesis            208.12      50082     12.97      4
  70         P10630                        Eukaryotic initiation factor 4A-II                          Protein biosynthesis            40.71       46373     2.38       1
  71         Q66H94                   Peptidyl-prolyl cis-trans isomerase (PPIase)                     Protein biosynthesis             44.5       63086     2.09       1
  72         Q8R2Y8                        Peptidyl-tRNA hydrolase 2 (PTH 2)                           Protein biosynthesis             50.9       19514     7.82       1
  73         Q9CY50              Translocon-associated protein subunit alpha precursor                 Protein biosynthesis            44.77       32045     5.15       1
  74       **Q62186**          **Translocon-associated protein subunit delta precursor**               Protein biosynthesis            58.73       18924      6.4       1
  75         Q60432                         150 kDa oxygen-regulated protein                              Protein folding              111.56      111202    3.56       2
  76         Q1PSW2                            84 kDa heat shock protein                                  Protein folding              268.13      83230     5.29       4
  77       **P24369**                              **Cyclophilin B**                                      Protein folding              159.73      22699     17.96      3
  78       **P30412**                              **Cyclophilin C**                                      Protein folding              111.37      22780     12.08      2
  79         Q8R180                 ERO1-like protein alpha precursor (ERO1-Lalpha)                       Protein folding              40.76       54004     2.45       1
  80         Q3U5T8                               t-complex protein 1                                     Protein folding              97.92       55438     4.17       2
  81         P80318                        T-complex protein 1 subunit gamma                              Protein folding              82.19       60591       2        1
  82         O70152                      Dolichol-phosphate mannosyltransferase                         Protein processing             41.77       29156      8.3       1
  83         Q3UC51           dolichyl-di-phosphooligosaccharide-protein glycotransferase               Protein processing             197.03      49011     9.44       4
  84         Q03145                        Ephrin type-A receptor 2 precursor                           Protein processing             77.94       108753    2.73       2
  85         O08795                       Glucosidase 2 subunit beta precursor                          Protein processing             42.18       58756     1.87       1
  86         P17439                           Glucosylceramidase precursor                              Protein processing             81.57       57585     4.59       2
  87       **P57716**                           **Nicastrin precursor**                                 Protein processing              48.9       78441     1.54       1
  88         P27773                     Protein disulfide-isomerase A3 precursor                        Protein processing             421.29      56586     18.29      8
  89         P38660                     Protein disulfide-isomerase A6 precursor                        Protein processing             264.65      48131     11.67      3
  90         Q8R4U2                   Protein disulfide-isomerase precursor (PDI)                       Protein processing             516.21      56975     27.85      9
  91         P52480                          Pyruvate kinase isozymes M1/M2                             Protein processing             257.65      57719     14.89      5
  92         Q91YQ5                                   Ribophorin I                                      Protein processing             47.47       68486     1.93       1
  93         Q9DBG6                                  Ribophorin II                                      Protein processing             97.57       69020     3.67       2
  94         Q00993                  Tyrosine-protein kinase receptor UFO precursor                     Protein processing             70.28       98188     1.23       1
  95       **Q6AXQ3**                      **Viral oncogene yes-1 homolog 1**                           Protein processing             36.55       54236     4.46       1
  96         Q3TFU8                            Glycoprotein 25L2 homolog                                 Protein transport             89.06       31239     7.42       2
  97         P62835                                 Rap-1A precursor                                    Ras-related protein            240.69      20974     18.42      4
  98         P80236              Ras-related C3 botulinum toxin substrate 1 (p21-Rac1)                  Ras-related protein            47.41        8805     17.5       1
  99       **P61226**                   **Ras-related protein Rap-2b precursor**                        Ras-related protein             69.2       20491     6.45       1
  100      **P62071**                   **Ras-related protein R-Ras2 precursor**                        Ras-related protein            79.46       23385     7.55       1
  101        Q61411                        Transforming protein p21 (p21ras)                            Ras-related protein            49.31       21335     6.22       1
  102      **P17852**                        **Integrin alpha-3 precursor**                                  Receptor                  329.02      118475    6.59       5
  103        P43406                            Integrin alpha-V precursor                                    Receptor                  120.21      115205    2.87       3
  104        P09055                            Integrin beta-1 precursor                                     Receptor                  90.71       88173      2.5       2
  105      **P61022**                       **Calcium-binding protein p22**                                 Signalling                 58.15       22287     5.94       1
  106      **P62204**                                **Calmodulin**                                         Signalling                 187.09      16696     30.46      3
  107      **P62874**                 **G protein G(I)/G(S)/G(T) subunit beta-1**                           Signalling                 186.51      37222     13.02      3
  108      **P62880**                 **G protein G(I)/G(S)/G(T) subunit beta-2**                           Signalling                  151        37176     13.06      3
  109        Q3HR13              Guanine nucleotide binding protein alpha inhibiting 2                      Signalling                 235.3       40419     14.17      4
  110        Q5EAP4                   Guanine nucleotide binding protein, alpha 14                          Signalling                 227.12      41415     12.5       4
  111        P21279              Guanine nucleotide-binding protein G(q) subunit alpha                      Signalling                 273.99      41457     20.21      5
  112        Q8R4A8              Guanine nucleotide-binding protein G(s) subunit alpha                      Signalling                 232.48      45621     13.04      5
  113      **P62977**                                **Ubiquitin**                                          Signalling                 114.62       8560     32.47      2
  114        O88736                             3-keto-steroid reductase                                Steroid metabolism             58.55       37293     3.54       1
  115        P47953                                    Galectin-3                                          Sugar binding               50.42       25592     4.31       1
  116        Q3U0D7                            ADP-ribosylation factor 6                                    Trafficking                37.23       20069     6.04       1
  117      **Q9CQW2**                 **ADP-ribosylation factor-like protein 8B**                           Trafficking                205.81      21525     17.44      4
  118        Q9DB05                Alpha-soluble NSF attachment protein (SNAP-alpha)                        Trafficking                173.24      33168     12.62      3
  119        P49020                     COPI-coated vesicle membrane protein p24                            Trafficking                66.59       22175     6.47       1
  120        P08113                              Endoplasmin precursor                                      Trafficking                334.23      92418      5.6       5
  121        P49130                                      LAMP-2                                             Trafficking                 41.5       44999     2.44       1
  122        O35604                        Niemann-Pick C1 protein precursor                                Trafficking                36.07       142795      1        1
  123        Q91ZX7      Prolow-density lipoprotein receptor-related protein 1 precursor (LRP)              Trafficking                107.05      504411    0.68       2
  124        O35074                              Prostacyclin synthase                                      Trafficking                170.13      57011     7.34       3
  125        Q9D0F3                            Protein ERGIC-53 precursor                                   Trafficking                 52.6       57753      2.1       1
  126      **Q4FJL0**                                  **RAB10**                                            Trafficking                174.32      22559     16.1       3
  127        P62492                                      RAB11A                                             Trafficking                51.03       24247     5.91       1
  128      **Q91V41**                                  **RAB14**                                            Trafficking                99.99       23751     11.16      2
  129        P62821                                      RAB1A                                              Trafficking                187.04      22532     19.12      3
  130      **P53994**                                  **RAB2A**                                            Trafficking                263.69      23533     30.52      5
  131        Q3UCX7                                      RAB5A                                              Trafficking                80.78       23585     11.68      2
  132      **P61021**                                  **RAB5B**                                            Trafficking                141.52      23692     20.47      3
  133      **Q3TCT9**                                  **RAB5C**                                            Trafficking                200.16      23398     23.11      4
  134      **Q3U4W5**                                   **RAB6**                                            Trafficking                269.71      23531     28.64      5
  135      **Q4AEF6**                                   **RAB7**                                            Trafficking                40.92       28557     3.47       1
  136      **Q3UZ06**                 **SEC22 vesicle trafficking protein-like 1**                          Trafficking                97.82       18935     6.98       1
  137      **Q8K021**                   **Secretory carrier membrane protein 1**                            Trafficking                40.66       38004     6.67       1
  138        Q62465                 Synaptic vesicle membrane protein VAT-1 homolog                         Trafficking                77.87       43069     3.58       1
  139        O88385                                   Syntaxin 12                                           Trafficking                55.46       31090     5.32       1
  140        Q3TSL5                                   syntaxin 4A                                           Trafficking                76.27       34204      7.1       2
  141        Q9JI92                                    Syntenin-1                                           Trafficking                109.68      32403     11.33      2
  142        Q61235                               Syntrophin-3 (SNT3)                                       Trafficking                162.55      56346     7.42       3
  143        Q07891                       Transferrin receptor protein 1 (TfR)                              Trafficking                51.95       85027     1.42       1
  144      **O35587**                  **Transmembrane protein Tmp21 precursor**                            Trafficking                152.47      24805     16.44      3
  145        P63024                  Vesicle-associated membrane protein 3 (VAMP-3)                         Trafficking                55.54       11473     15.38      1
  146      **Q791V5**                     **Mitochondrial carrier homolog 2**                               Transporter                71.58       33477     7.89       1
  147        Q7TP91                                     Ab1-205                                      Unknown cellular process          50.91       83209     1.72       1
  148        Q9D7N9                   Adipocyte plasma membrane-associated protein                   Unknown cellular process          94.98       46405     5.46       2
  149        P20944                              CD44 antigen precursor                              Unknown cellular process          142.8       39750     4.99       2
  150        Q9QV38                                       ERP6                                       Unknown cellular process          54.19        2112     73.68      1
  151        Q8BLN5                        Lanosterol synthase (EC 5.4.99.7)                         Unknown cellular process           68.6       83088     1.85       1
  152        Q6P7S1                        N-acylsphingosine amidohydrolase 1                        Unknown cellular process          150.07      44415     10.42      3
  153        P97300                              Neuroplastin precursor                              Unknown cellular process           60.1       31258     3.52       1
  154      **Q9Z239**                         **Phospholemman precursor**                            Unknown cellular process          38.49       10316     12.9       1
  155        O55221                              Putative CD98 protein                               Unknown cellular process          63.88       58889     3.74       1
  156        Q9JK11                                   Reticulon-4                                    Unknown cellular process          59.01       126310    1.13       1
  157        Q9CWD1                             similar to DB83 PROTEIN                              Unknown cellular process          66.14       19857     6.67       1
  158      **Q3TIP1**                         **solute carrier family 3**                            Unknown cellular process          55.26       10997     17.17      1
  159        Q5XIK2                Thioredoxin domain-containing protein 14 precursor                Unknown cellular process          39.08       33844     3.91       1
  160        Q2TBF8                   Transmembrane 9 superfamily protein member 4                   Unknown cellular process          41.68       74584     1.33       1
  161      **Q6P791**                     **UPF0404 protein C11orf59 homolog**                       Unknown cellular process          116.65      17710     16.25      2

Mw: theoretical molecular weight (kDa). Cov (%), protein sequence coverage; Nb pep, number of peptides assigned. In bold are the proteins found in both DRM and DSM fractions.

As illustrated in [Fig. 1](#pone-0002758-g001){ref-type="fig"}, proteins forming the largest group, in both fractions, were involved in trafficking, confirming that late endosomes are implicated in intensive communication with other compartments. In particular, several small GTPases of the Rab family, in addition to Rab7 well known to localize to late endosomes, were found, in agreement with other proteomic studies [@pone.0002758-Schroder1] and suggesting a more complex role/localization of Rabs than expected.

![Graphic representation of the main functional categories found in the proteomic studies.\
A: DRM fraction, B: DSM fraction.](pone.0002758.g001){#pone-0002758-g001}

Interestingly many of the identified proteins were involved in signaling, in particular in the DRMs, such as the α and ß subunits of several G proteins, as also reported by others reported [@pone.0002758-Schroder1], [@pone.0002758-VanDyke1]. The presence of these proteins in late endosomes supports the notion that endosomes are active signaling sites [@pone.0002758-GonzalezGaitan1] and that cholesterol rich domains are important in organizing signaling platforms [@pone.0002758-Roy1].

However, the most striking finding to us was the identification of all the subunits of the V-ATPase (a1, c and d from the V0 subunit and A, B2, C, D, E, F, G2 and H from the V1 subunit) exclusively in the DRM fraction. This observation suggested that the V-ATPase may localize to specific membrane domains within late endosomes and that this could be important for its function or the regulation of its activity.

There is increasing evidence that the V-ATPase can interact with numerous regulatory proteins, and thus we investigated whether some of these proteins came up in our proteomics analysis. The H-subunit, which shows homology to ß-adaptins [@pone.0002758-Geyer1], was found to interact with the m2-chain of AP2 adaptor and promotes clathrin-coated vesicle (CCV) formation [@pone.0002758-Geyer1]. Interestingly we found three of the subunits of the adaptor complex AP-2, in the late endosomal DRM fraction. Functional AP-2 complex was previously observed in lysosomes and found to support clathrin assembly and bud formation [@pone.0002758-Keyel1], [@pone.0002758-Traub1]. We also found the small GTPase Arf6, albeit in DSM fraction. Arf6 was found to interact with the Vo c subunit and it was proposed that through this interaction, the vATPase could modulate membrane trafficking in the endosomal system [@pone.0002758-HurtadoLorenzo1]. In addition to mediating proton transport, it has been proposed that the Vo subunit is involved in vesicles fusion both in yeast [@pone.0002758-Peters1] and in higher eukaryotes [@pone.0002758-Hiesinger1], [@pone.0002758-Liegeois1]. Numerous proteins involved in membrane fusion were found in the DRM fraction including SNAP-23, syntaxin 8, VAMP-A and the v-SNARE like protein Vtil-rp1.

Finally the dissociation of the V1/vo complex, in yeast, has been shown to require an intact microtubule network [@pone.0002758-Xu1] and well aldolase, which would act as a glucose sensor and signal for the dissociation of the V-ATPase [@pone.0002758-Lu1]. Both tubulin and aldolase were detected in our proteomic analysis. Interestingly aldolase was only found in the DSM fraction and it is tempting to speculate that spatial segregation between the V-ATPase and aldolase is necessary to prevent uncontrolled disassembly of the complex. Clearly, non transmembrane proteins could also be removed from the detergent resistant domains during the solubilization.

DRM association of the V-ATPase {#s2b}
-------------------------------

To validate the DRM association of the V-ATPase revealed by the proteomic analysis, we performed a Western blot analysis probing for V-ATPase subunits of the V~1~ and V~0~ domains. Distribution of the V0 domain was monitored by following the d subunit and distribution of the V1 domain by following the A subunit. Both V~0~d and V~1~A subunits were found in the DRM fractions of both late endosomes and early endosomes ([Fig. 2](#pone-0002758-g002){ref-type="fig"}). Note that the total protein content of each fraction was analyzed in [Fig. 2](#pone-0002758-g002){ref-type="fig"}, as opposed to the same amount of protein. [Fig. 2](#pone-0002758-g002){ref-type="fig"} thus shows that the majority of the V-ATPase localized to DRMs, showing a distribution similar to that of Flotillin-1, a well-established marker of DRM fractions [@pone.0002758-Morrow1].

![Association of V1 and V0 domains of the V-ATPase with the DRMs of early and late endosomes.\
Late (A) and early (B) endosomes were purified from BHK cells and the fractions were submitted to solubilization in 1% triton X-100 at 4°C. The Triton X-100 treated fractions were subsequently loaded at the bottom of an OptiPrep gradient. After centrifugation, 6 fractions were collected from the top and analyzed by SDS-PAGE followed by Western blotting to detect flotilin-1, Rab7, the vATPas subunits V0d and V1A.](pone.0002758.g002){#pone-0002758-g002}

Effects of U18666A treatment on the acidification of late endosomes {#s2c}
-------------------------------------------------------------------

The above experiments show that all along the endocytic pathway, from early to late endosomes, the V-ATPase exhibits a strong affinity for DRMs suggesting its preference for cholesterol rich, ordered membrane domains. To evaluate the physiological relevance of these findings, we investigated whether perturbing cholesterol rich domains in late endosomes would affect the function of the V-ATPase, by monitoring the acidity of late endosomes.

We first investigated whether extraction of cholesterol from cells using ß-methylcyclodextrin (ß-MCD) would lead to a change in late endosome acidification. Cells were treated with 10 mM ß-MCD for 55 min leading to an ≈50% decrease in total cholesterol content [@pone.0002758-Abrami1]. As illustrated in [Fig. S1](#pone.0002758.s001){ref-type="supplementary-material"}, ß-MCD treatment led to a significant increase in late endosomal pH, supporting the notion that alteration of cholesterol rich domains affects the function of the V-ATPase. These findings however need to be taken with a word of caution, since we have no evidence that extraction of cholesterol from the plasma membrane actually leads to a significant reduction of cholesterol in late endosomes. Indeed when purifying late endosomes from ß-MCD treated cells, we could not detect a significant change in cholesterol, as analyzed by thin layer chromatography, a technique that might not be sensitive enough to detect small changes (10--20%). We therefore decided to induce perturbation of late endosomal membrane domains by treating cells with the negatively charged amine 3beta-(2-diethylaminoethoxy)-androstenone HCl (U18666A) [@pone.0002758-Koh1], which leads to the accumulation of cholesterol in late endosomes, through unknown mechanisms, and to alterations in the membrane dynamics of this compartment [@pone.0002758-Sobo2]. Treatment for 18 hrs with U18666A mimics the Niemann Pick type C phenotype [@pone.0002758-Sobo2], [@pone.0002758-Koh1], [@pone.0002758-Liscum1] showing a drastic cholesterol accumulation in late endosomes ([Fig. 3CF](#pone-0002758-g003){ref-type="fig"} and [4CF](#pone-0002758-g004){ref-type="fig"}).

![Effects of U18666A treatment on the pH at the limiting membrane (FITC-Lamp1) of late endosomes.\
Lamp1-FITC was internalized overnight at 37°C by control cells (A, B, C) and cells treated by U18666A (D, E, F). Typical examples of the respective labels are shown (B and E). The pH of individual organelles was measured by fluorescence ratio imaging of internalized Lamp1-FITC. The histograms show the pH distribution of 2304 and 2325 endosomes for the upper and the lower panels, respectively, with the mean±SD given in the left panels (A and D). Pseudocolor pH scale is on the side. Histograms of vesicles of cells treated with bafilomycin are shown as a control. The observed difference is significant according to a paired t-test with p\<0.001. Cells were checked for their phenotype of cholesterol accumulation with filipin staining (C and F). Bars, 10 µm.](pone.0002758.g003){#pone-0002758-g003}

![Effects of U18666A treatment on the pH of late endosomal lumen (FITC-dextran).\
FITC-dextran was internalized for 15 minutes and chased for 40 minutes at 37°C in control cells (A, B, C) and cells treated by U18666A (D, E, F) to allow it to reach late endosomes. Typical examples of the respective labels are shown (B and E). The pH of individual organelles was measured by fluorescence ratio imaging of internalized FITC-Dextran. Pseudocolor pH scale is on the side. The histograms show the pH distribution of 3346 and 3880 endosomes for the upper and the lower panels, respectively, with the mean±SD given in the left panels (A and D). The observed difference is significant according to a paired t-test with p\<0.001. Cells were checked for their phenotype of cholesterol accumulation with filipin staining (C and F). Bars, 10 µm.](pone.0002758.g004){#pone-0002758-g004}

The pH measurements were performed by fluorescence ratio imaging, using the pH sensitive florescent probe FITC (fluorescein isothiocyanate) [@pone.0002758-Demaurex1]. We used two different probes: FITC coupled to dextran, which was endocytosed by fluid phase and thus provides information on the bulk of the endosomal lumen, and FITC coupled to a monoclonal antibody, 4A1, against the luminal domain of the hamster late endosomal protein Lamp1. Lamp1 localizes specifically to the limiting membrane of late endosomes [@pone.0002758-Kobayashi1] --this organelle being multivesicular [@pone.0002758-Gruenberg1]--, and thus FITC anti-lamp1 allows the measurement of the pH in the vicinity of the limiting membrane. We find that the 4A1 anti-Lamp1 antibody internalized overnight ([Fig. 3B, 3E](#pone-0002758-g003){ref-type="fig"}), reaches late endosomes where it binds to its antigen (co-localizing with the late endosomal lipid LBPA, not shown) and is not degraded, in agreement with observations by others [@pone.0002758-Kobayashi2], [@pone.0002758-Petiot1]. In contrast, a none specific antibody endocytosed at the same concentration was degraded in late endosomes/lysosomes, as documented by others [@pone.0002758-Petiot1]. The fluid phase fluorescent probe, FITC-Dextran was internalized for 15′ and chased for 40′ in order to reach late endosomes ([Fig. 4B, 4E](#pone-0002758-g004){ref-type="fig"}). Importantly we have previously shown that U18666A treatment does not prevent transport to late endosomes [@pone.0002758-Sobo2]. Series of images were taken at both 440 nm and 490 nm, prior to calibration with different pH solutions, which allows the translation of ratio values into pH values. As illustrated by the pseudocolor images ([Fig. 3B](#pone-0002758-g003){ref-type="fig"}, [4B](#pone-0002758-g004){ref-type="fig"}) and quantified in the distribution histograms ([Fig. 3A](#pone-0002758-g003){ref-type="fig"}, [4A](#pone-0002758-g004){ref-type="fig"}), the pH of late endosomes in control cells varied between 4.85±0.40 and 5.09±0.44 depending on the probe used, a pH that was neutralized upon treatment with the V-ATPase specific inhibitor bafilomycin ([Fig. 3A](#pone-0002758-g003){ref-type="fig"}). Late endosomes of U18666A cells were however 0.41 (using anti-lamp1 FITC) to 0.88 (using FITC dextran) pH units less acidic than late endosomes from control cells, yet pH was still sensitive to bafilomycin, suggesting that acidity was still mainly due to the V-ATPase.

We next analyzed the effect of U18666A biochemically, monitoring the association of the V-ATPase subunits with membranes. Post nuclear supernatant (PNS) from control and U18666A treated BHK cells were submitted to high-speed centrifugation to separate the membranes (P: pellet) from the cytosol (SN: supernatant). As expected for a V~0~ domain subunit, V~0~d was entirely membranes associated, irrespective of U18666A treatment. In contrast, the majority of V~1~E was in the cytosolic fraction of control cells with only a minor fraction associated with membranes. Interestingly, this distribution was reversed upon U18666A treatment, leading a two-fold increase in the membrane to cytosol ratio of the V~1~E subunit ([Fig. 5](#pone-0002758-g005){ref-type="fig"}). This result indicates that the lipid composition of the membrane, and possibly the degree of order of the membrane, affects the V1-V0 association/dissociation of the V-ATPase. The observations are compatible with a higher V1 off rate in a more fluid membrane. The transport of protons by the V-ATPase requires the association of the V1 sector with the V0. Therefore an increased association of V1 with membranes as observed upon U18666A would a priori be expected to lead to an increased activity and thus more acidic endosomes. Yet U18666A led to a decrease in acidity. Together these observations suggest that U18666A altered the dynamics of association/dissociation, which appear to be essential for proper V-ATPase function, leading to a locked configuration of the V-ATPase.

![Increase of V1 association to membrane upon U18666A treatment.\
PNS was submitted to high speed spinning and pellet (P) and supernatant (SN) were loaded on a gel. Western blotting was revealed with V0d and V1E subunit antibody. Quantification reveals that upon U18666A treatment, V1E is 4-fold more associated with the membrane (pellet) than in control cells.](pone.0002758.g005){#pone-0002758-g005}

Increase of the V~1~/V~0~ ratio along the endocytic pathway {#s2d}
-----------------------------------------------------------

The above observation suggests that the membrane environment influences the activity of the V-ATPase. This does not exclude other mechanisms of regulation and in particular we found that the V-ATPase was associated with DRMs in both early and late endosomes, rendering it unlikely that membrane localization is the sole responsible for the different pH in early and late endosomes. We therefore investigate whether association/dissociation of the V1 domain form the V0 domain, the regulatory mechanism found in yeast, could contribute to the increase in acidity along the endocytic pathway. Early and late endosomes fractions, enriched in the transferrin receptor and the late endosomal lipid lysobisphosphatidic acid (LBPA, used a marker of late endosomes) respectively ([Fig. 6A and 6B](#pone-0002758-g006){ref-type="fig"}), were obtained by differential centrifugation from BHK cells and separated from heavy membranes containing the endoplasmic reticulum and the Golgi ([Fig. 6](#pone-0002758-g006){ref-type="fig"}). As expected, the V~0~ and V~1~ subunits, revealed with anti- V~0~d and anti-V~1~B respectively, were detected in both early and late endosomes ([Fig. 6A](#pone-0002758-g006){ref-type="fig"}). As observed through the analysis of multiple experiments, the enrichment of the V0 subunit d was quite similar in early and late endosomes indicating that the density of the proton translocator subunit was the same in both compartments (not shown). What was strikingly different between early and late endosomes was however the relative abundance of the V1 domain, as witness by following the B ([Fig. 6A](#pone-0002758-g006){ref-type="fig"}), the A or E subunits (data not shown): the V1/V0 ratio was always higher in late than in early endosomes, as quantified from several experiments in [Fig. 6B](#pone-0002758-g006){ref-type="fig"} (n = 3, note that the ratios only have a relative meaning and do not provide stochiometric information because the antibodies against the two subunits are by definition different). The higher V1/V0 ratio in late vs. early endosomes correlates with the higher acidity of this compartment, suggesting that an increase in V-ATPase activity through an increase in V1-V0 association is the underlying mechanism and that this mechanism of regulation is not restricted to yeast [@pone.0002758-Kane2], [@pone.0002758-Kane3] and maturing dendritic cells [@pone.0002758-Trombetta1].

![Increased assembly of the two sectors of the V-ATPase in late endosome.\
Subcellular fractionation of postnuclear supernatants (PNS) was performed to separate early (EE) from late endosomes (LE) and heavy membranes (HM) A: 20 µg of protein from each fraction were separated in 12.5% SDS-PAGE and blotted for the presence of TfR (early endosomal marker), V0d and V1B. B: The late endosomal lipid LBPA was used to follow the distribution of late endosomes on the gradient. An equal amount of protein was used for LBPA detection by ELISA with the LBPA antibody (6C4). C: Western blot was quantified using a Phosphoimager (Bio-Rad Laboratories) and the ratio V1/V0 was plotted. Note that the ratio LE/EE is higher for the V1B subunit than for the V0d subunit suggesting a higher assembly of the V-ATPase in the late endosomes compared to early endosomes.](pone.0002758.g006){#pone-0002758-g006}

Discussion {#s3}
==========

Endosomes are the most acidic organelles in mammalian cells, yet little is known about the exact mechanisms that regulate their pH and how acidity increases along the endocytic pathway. Although the V-ATPase is the main contributor to this acidity, how its activity is regulated is to a large extent unknown. The main mechanism described to date is the reversible dissociation of the V~0~ and V~1~ domains of the V-ATPase. It was first discovered in yeasts and insects. In these organisms however, dissociation appears as a survival mechanism to conserve the ATP stock upon conditions of energy limitation by glucose deprivation or starvation [@pone.0002758-Kane1], [@pone.0002758-Kane2], [@pone.0002758-Sumner1]. The known glucose-induced signaling pathways do not seem to be involved since mutants in the ras-cyclic AMP pathway or in the protein kinase C pathway, continue to assemble in the presence of glucose [@pone.0002758-Kane1], [@pone.0002758-Parra1]. Regulation by reversible dissociation has also been described in specialized mammalian cells, such as renal epithelial cells, where reversible dissociation is, as in yeast, coupled to glucose levels [@pone.0002758-Sautin1], [@pone.0002758-Breton1]. The only situation in which changes in V1-V0 association were aimed at controlling endosomal pH was during maturation of dendritic cells, where increased acidification was shown to increase the activity of hydrolytic enzymes and thus the efficiency of antigen processing [@pone.0002758-Trombetta1]. Our work suggests that, as in maturing dendritic cells, increased assembly of the V-ATPase sectors along the endocytic pathway of fibroblast-like cells contributes to increasing the acidity of the organelles.

Changes in V1-V0 association raise the questions of the mechanisms that regulate this process. Our striking finding that all the subunits of the V-ATPase localized to the DRM fraction and that treatment of cells with U18666A, which affects late endosomal cholesterol levels, lead to an increase in V1-V0 association, together point to a role of the membrane composition in controlling the rate of V1-V0 association-dissociation. This could be either through the direct effect of specific lipids on the V-ATPase mediated by a lipid-protein interaction, or/and through an effect of the membrane fluidity. High fluidity, as possibly found at the plasma membrane, would lead to V1 dissociation and a drop in V-ATPase mediated acidification. Similarly low membrane fluidity, as promoted by U18666A dependent cholesterol accumulation, would lead to a too strong V1-V0 interaction preventing proper function of the proton pump, and thus again reduction in activity. The effect of U18666A is reminiscent of the marine-derived V-ATPase inhibitor salicylihalamide A. This metabolite binds to the Vo complex, as do Bafilomycin A or concanamycin, but to a different site. More strikingly, salicylihalamide A triggers a dramatic redistribution of the V1 complex from the cytoplasm to the endosomes, a redistribution not observed with the other inhibitors [@pone.0002758-Xie1]. The paradoxical effects of U18666A and salicylihalamide A suggest that excessive stabilization of the V1-V0 complexes is detrimental to the pumps activity.

The hypothesis that raft-like domains are involved in regulating the activity of the mammalian V-ATPase is further supported by findings by others, in yeast, that sphingomyelin [@pone.0002758-Chen1], and possibly ceramide [@pone.0002758-Dawson1] modulate the function of the V-ATPase. Interestingly, ceramide was also found to be required for oligomerization of the plasma membrane proton ATPase in yeast [@pone.0002758-Lee1].

We wish to mention that the V-ATPase has previously been found in a raft fraction of the plasma membrane of neurons [@pone.0002758-Yoshinaka1]. However only components of the V0 domain were identified. In contrast, we here found all eight V1 subunits ([table 1](#pone-0002758-t001){ref-type="table"}). Yoshinaka et al. [@pone.0002758-Roy1] hypothesize that the V-ATPase may disassemble during sample preparation or that the V0 sector selectively associates with rafts. Our results show that both V1 and V0 sectors can be recovered in the DRM fraction. The apparent discrepancy between the two studies could be due to the fact that plasma membrane fractions were analyzed in the first study and that the V-ATPase is mostly disassembled at that cellular site as opposed to endosomes studied here. This interpretation is supported by our finding that assembly of V1 and V0 increases along the endocytic pathway and would thus be lowest at the cell surface.

The here identified effect of membrane composition on the activity of the V-ATPase suggests that diseases that affect lipid distribution or composition, in particular in the endocytic pathway, may lead to alterations in endosomal pH. It will therefore be of interest to determine if endosomal pH is affected in cells from patients suffering from lipid storage diseases such as Niemann Pick type C and how this affects endosomal function.

Materials and Methods {#s4}
=====================

Cell, reagents and drug treatment {#s4a}
---------------------------------

Monolayers of Baby hamster kidney (BHK) cells were grown and maintained as described previously [@pone.0002758-Abrami2], [@pone.0002758-Gruenberg2]. The monoclonal antibodies against LBPA (6C4) and Lamp 1 (4A1) have been described [@pone.0002758-Kobayashi2], [@pone.0002758-Kobayashi3]. Monoclonal anti-transferrin receptor antibodies were from Zymed Laboratories Inc. Rabbit polyclonal anti-flotillin antibodies were produced by our laboratory [@pone.0002758-Fivaz1]. Polyclonal antibody against the 39-kDa subunit of the V-ATPase (V0d) was previously described [@pone.0002758-Schapiro1]. Rabbit polyclonal antibodies against V1 subunit A and V1 subunit E were kind gifts from I. Schultz and antibodies against V1 subunit B were produced by Eurogentech. Rhodamine-dextran (10,000 Da) was from Molecular Probes. For pH measurement, Lamp1 antibody was labeled with FITC (Fluo reporter labeling kit) from Molecular probes. Cells were treated with 3beta-(2-diethylaminoethoxy)-androsterone HCl (U18666A) as described [@pone.0002758-Sobo2]. Briefly, the cell culture medium was removed 4 hours after plating and fresh medium containing U18666A at 3 µg/ml was added for 18 hours.

Subcellular fractionation and Immunoblotting {#s4b}
--------------------------------------------

Early and late endosomal fractions were prepared as described [@pone.0002758-Aniento1], [@pone.0002758-Sobo2]. Briefly, BHK cells were homogenized, a post nuclear supernatant (PNS) was prepared, adjusted to 40.6% sucrose, loaded on the bottom of a SW41 tube and overlaid sequentially with 35%, 25% and 8.5% sucrose solution in 3mM imidazole, pH 7.4. The gradient was centrifuged for 90 minutes at 35000 rpm. Heavy membranes, early and late endosomal fractions were collected at the 40.6/35%, 35/25% and 25/8.5% interfaces respectively. Proteins were separated by SDS-PAGE using 12.5% acrylamide gels and transferred onto a nitrocellulose membrane. Western blots were revealed with SuperSignal Chemiluminescence (Pierce) and quantified by densitometry.

Isolation of DRMs from early and late endosomal fraction {#s4c}
--------------------------------------------------------

DRMs were prepared from late endosomes as described [@pone.0002758-Fivaz1]. Early or late endosomes were diluted four times, sedimented by centrifugation (TLS55 Beckman Rotor, 30 min, 55000 rpm) and resuspended in 200 µl of lysis buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA) in the presence of Complete, a cocktail of protease inhibitors (Roche) and 1% Triton X-100. After 20 min of incubation at 4°C, the lysat was adjusted to 40% OptiPrep (Nycodenz), overlaid with 30% and 0% OptiPrep cushions and centrifuged for two hours at 55000 rpm (4°C) using a TSL55 rotor. Six fractions were collected and precipitated with 6% trichloroacetic acid in the presence of sodium deoxycholate as a carrier.

Sample preparation for mass spectrometry analysis {#s4d}
-------------------------------------------------

DRMs and DSMs fractions were prepared from late endosomes (200 µg) as explained in precedent paragraph. 30 µg proteins from recovered DRMs and DSMs fractions were precipitated using methanol/chloroform. Proteins were then run on 2 cm in one-dimensional SDS-PAGE (15% acrylamide gel, 0.75 mm thick). Protein bands (12, and 14 for DRMs and soluble fraction, respectively) were excised and destained by repeated cycles of incubation in 25mM NH~4~HCO~3~ for 15 min and then with 50% (v/v) ACN in the same buffer (25mM NH~4~HCO~3~) for 15 min. After drying by vacuum centrifugation, the gel pieces were incubated with an oxidizing solution (7% H~2~O~2~) for 15 min [@pone.0002758-Jaquinod1]. Gel pieces were then washed in HPLC grade water (Sigma-Aldrich) for 15 min before being dehydrated with 100% ACN. In-gel digestion was performed (0.5 µg trypsin/band; sequencing grade modified trypsin, Promega) in 25mM NH~4~HCO~3~ overnight at 37°C. Peptides were extracted from the gel using passive diffusion in the following solutions: 50% ACN, then 5% formic acid, and finally 100% ACN. The extracts were dried by vacuum centrifugation and peptides were resolubilized in 5% ACN, 0.2% formic acid.

MS/MS analysis {#s4e}
--------------

The different sample fractions were injected into a CapLC nanoLC system (Waters) and first preconcentrated on a 300 µm×5 mm precolumn (PepMap C18; Dionex). The peptides were then eluted onto a C18 column (75 µm×150 mm; Dionex). Chromatographic separation used a gradient transition from solution A (2% acetonitrile, 98% water and 0.1% formic acid) to solution B (80% acetonitrile, 20% water and 0.08% formic acid) over 60 min at a flow rate of 200 nl/min. The LC system was directly coupled to a mass spectrometer (QTOF; Waters). MS and MS/MS data were acquired and processed automatically using MassLynx software (Waters). Database searching was performed using MASCOT 2.2 software (Matrix Science) using SwissProt_Trembl as the database and Rodent as the taxonomy. Variable modifications accorded were: Acetyl N-terminal of protein, simple and dioxidation of Methionine and cysteic acid on cysteine. Precisions on both MS and MS/MS data were set to 0.3 Da. The .dat files obtained through Mascot were further filtered using an "in-house" parsing solution (Irma, to be published: *Bioinformatics* Application Notes) build from Mascot Parser. The two sets of data were checked for false positive but none were found. Peptides whose score were \> =  to query identity threshold (p\<0.05) and rank \< = 1 were marked as significant through a first filtering and at final, a manual validation was done on proteins containing only one or two peptides. The peptide sequences were considered as validated if they contained at least 3 consecutives Y or B ions with a S/N threshold \>3. Classical MS contaminants such as trypsin and keratin proteins were removed manually.

Fluorescence microscopy {#s4f}
-----------------------

Cells grown on cover slips were fixed with 3% paraformaldehyde for 20 min at room temperature and saturated with 10% phosphate-buffered saline-fetal calf serum (PBS-FCS) for 20 min. Cholesterol was labeled with 50 µg/ml Filipin in 10% PBS-FCS.

pH measurements {#s4g}
---------------

BHK cells grown on glass cover slips, were incubated with a FITC conjugated Lamp1 antibody overnight at 37°C or a FITC dextran for 15 minutes at 37°C and washed for 40 minutes. Late endosomal pH was measured by ratio fluorescence imaging as described [@pone.0002758-Demaurex2], [@pone.0002758-Piguet1] with the use of a Nipkow dual spinning disk confocal laser imaging system with a QLC module (Visitron systems GmbH, Switzerland). Cover slips were inserted into a perfusion chamber (Medical Systems, Green- vale, NY) at 37°C in 1 ml of IM medium and imaged with a video/CCD camera controlled by MetaMorph/Metafluor imaging software. Images were acquired for 500 ms at two different wavelengths, using the two lasers 490 and 440 nm. Calibration and image processing were performed as described previously [@pone.0002758-Demaurex2]. Data were graphed using the Prism software.

Supporting Information {#s5}
======================

###### 

Effects of β−MCD treatment on the pH of late endosomal lumen (FITC-dextran). FITC-dextran was internalized for 15 minutes and chased for 40 minutes at 37°C in control cells (A) and cells treated by β−MCD (B) to allow it to reach late endosomes. The histograms show the pH distribution of 3700 and 2194 endosomes for the upper and the lower panels. Values represent the mean±SD. The observed difference is significant according to a paired t-test with p\<0.001.

(1.24 MB TIF)
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Click here for additional data file.
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